Brand Name :
myfembree
Synonyms :
Class :
Gonadotropin-releasing hormone antagonists, estrogens/progestins
Dosage Forms & Strengths
Tablet
40mg/1mg/0.5mg
One tablet orally every day as soon as the menses start but not later than seven days
One tablet orally every day as soon as the menses start but not later than seven days
may reduce the therapeutic effect of gallium
may increase the hypoglycemic effect of blood glucose-lowering agents
may increase the hepatotoxic effect of cyclosporine
may decrease the diagnostic effect when combined with Piflufolastat F18
May increase the hypoglycemic effect of Agents with Blood Glucose Lowering Effects
it decreases by affecting the hepatic enzyme CYP3A4 metabolism
may have an increased hypertensive effect when combined with Androgens
may have an increased hypertensive effect when combined with Androgens
may have an increased hypertensive effect when combined with Androgens
may have an increased hypertensive effect when combined with Androgens
may have an increased hypertensive effect when combined with Androgens
may enhance the hypoglycemic effect
may enhance the hypoglycemic effect
may enhance the hypoglycemic effect
may enhance the hypoglycemic effect
may enhance the hypoglycemic effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the hypoglycemic effect
they increase the effect of androgens
may increase the hypertensive effect of hypertension-associated agents
may increase the hypertensive effects of hypertension associated agents
may increase the fluid-retaining effect of corticosteroids
may enhance the hypertensive effect of Androgens
may enhance the hypertensive effect of Androgens
may enhance the hypertensive effect of Androgens
may enhance the hypertensive effect of Androgens
may enhance the hypertensive effect of Androgens
may increase the hypoglycemic effect of Agents with Blood Glucose Lowering Effects
may increase the hypertensive effect of Hypertension-Associated Agents
It may increase the thrombogenic effect when combined with C1 inhibitors
may increase the hypoglycaemic effect with blood glucose lowering agents
may increase the hypoglycemic effect of Antidiabetic Agents
may increase the Glucose-lowering effect of Agents with Blood Glucose Lowering Effects
androgens increase the effect of hypoglycemia in these agents
androgens increase the effect of hypoglycemia in these agents
androgens increase the effect of hypoglycemia in these agents
androgens increase the effect of hypoglycemia in these agents
androgens increase the effect of hypoglycemia in these agents
androgens increase the toxic or adverse effect of ajmaline
may increase the hypertensive effect of hypertension-associated agents
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
androgens increase the effect of thrombogenesis of C1 inhibitors
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
Androgen Deprivation Therapy Agents decrease the effect of diagnosis of flotufolastat F18
Frequency defined:
>10%
Vasomotor symptoms
Hyperhidrosis
Increased total cholesterol
1-10%
Uterine fibroids
Anxiety
Irritability
Alopecia
Decreased libido
Breast cyst
Depression
Abnormal uterine bleeding
Endometriosis pain
Arthralgia
Dizziness
Mood disorders
Nausea
Back pain
Peripheral edema
Fatigue
Vulvovaginal dryness
<1%
Uterine leiomyoma
Low trauma fractures
Uterine myoma expulsion
Frequently undefined
Suicidal thoughts
Post-marketing reports
Drug eruption
Pulmonary embolism
Anaphylactoid reaction
Pregnancy consideration: The usage of the drug during pregnancy is contraindicated
Lactation: Excretion of the drug is unknown in human breast milk
Pregnancy category:
Patient information leaflet
GenericName: Relugolix/estradiol/norethindrone
Pronounced:REL-ue-GOE-lix/ES-tra-DYE-ol/nor-ETH-in-drone
Why do we use Relugolix/estradiol/norethindrone?
It helps premenopausal women with excessive menstrual bleeding caused by uterine fibroids under control (before menopause)
ADVERTISEMENT
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
